Cargando…
Hepatoblastoma: A Need for Cell Lines and Tissue Banks to Develop Targeted Drug Therapies
Limited research exists regarding the most aggressive forms of hepatoblastoma. Cell lines of the rare subtypes of hepatoblastoma with poor prognosis are not only difficult to attain but also challenging to characterize histologically. A community-driven approach to educating parents and families, re...
Autores principales: | Rikhi, Rishi Raj, Spady, Kimberlee K., Hoffman, Ruth I., Bateman, Michael S., Bateman, Max, Howard, Lisa Easom |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4800278/ https://www.ncbi.nlm.nih.gov/pubmed/27047905 http://dx.doi.org/10.3389/fped.2016.00022 |
Ejemplares similares
-
Neuropilin-2 Is Associated With Increased Hepatoblastoma Cell Viability and Motility
por: Eloranta, Katja, et al.
Publicado: (2021) -
Surgical resection of pediatric PRETEXT III and IV hepatoblastoma: A retrospective study investigating the need for preoperative chemotherapy
por: Wu, Xiongwei, et al.
Publicado: (2022) -
Case Report of Congenital Hepatoblastoma With the Onset at 30-Weeks' Gestation
por: Yan, Zheng, et al.
Publicado: (2022) -
Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as predictive markers in hepatoblastoma
por: Xie, Tan, et al.
Publicado: (2023) -
Congenital hepatoblastoma presenting with hepatic arteriovenous fistulas: a case report
por: Lin, Jiao, et al.
Publicado: (2023)